The Latest

Webinar recap: How Cigna is Innovating their Network Design Process

  On December 16th, we hosted an AHIP webinar discussion about how Cigna is innovating their network design process for market expansion. Health plan experts from Clarify Health, Dr. Jegar Jasani and Chuck Feerick, interviewed two leaders from Cigna, Austin Scott and Blake Amos. Austin has spent the last eight years [...]

2021-01-22T10:40:58-08:00January 22nd, 2021|

New Research: Telehealth Trends Among the Commercially Insured

Much like how many consumers are turning to Amazon or Instacart delivery instead of in-store shopping during the pandemic, early data suggests that large swaths of the US population are choosing telehealth encounters instead of in-person visits with their healthcare providers. However, a key difference between the virtualization of services [...]

2021-01-15T17:19:14-08:00January 19th, 2021|

Clarify Health renews certification as a CMS Qualified Entity and publishes research on national provider performance measures

Today, we announced that Clarify will continue to receive 100% of Medicare Fee-for-Service claims data through the Qualified Entity (QE) Program (also known as the Medicare Data Sharing for Performance Measurement Program) by the Centers for Medicare and Medicaid Services (CMS). Being a CMS Qualified Entity means that we will continue to expand the breadth, [...]

2021-01-12T06:43:43-08:00January 12th, 2021|

Diversity, equity, and inclusion in today’s healthcare institutions

Enhancing diversity, equity, and inclusion (DEI) in our healthcare institutions is essential. Unfortunately, the healthcare industry is no different from the many other sectors persistently challenged to prioritize and improve cultural competence – which is responding appropriately to people of varying backgrounds in a way that recognizes differences and allows individuals to [...]

2021-01-07T15:31:56-08:00January 8th, 2021|

The analytics your life sciences BD&L team could be missing

Whether you’re sizing the addressable market for a specific disease area or refining your pricing assumptions for a potential new asset, you need analytics that can give you the most precise inputs, fast.  We released a new analytics software, called Clarify Portfolio, to help business development and licensing (BD&L) teams make better investment decisions. It arms you with the input needed to gauge the true [...]

2021-01-06T16:42:15-08:00January 6th, 2021|